Futura Medtech, a portfolio company of Jashvik Capital, has made a strategic investment in Rivarp Medical Private Limited.

Lakshmikumaran & Sridharan Attorneys advised Jashvik Capital and Futura Medtech on this transaction. The firm’s role included conducting legal due diligence on Rivarp Medical, drafting and negotiating the definitive transaction documents, and assisting with closing and completion-related matters.

The transaction team consisted of Gaurav Dayal (Executive Partner), Sushrut Biswal (Partner), Sukoon Dinodia (Senior Associate) and Chetan Soni (Associate).

The investment aligns with Jashvik Capital’s strategy of building a scaled, multi-category medical devices platform with strong domestic and global market access through Futura Medtech.

Rivarp Medical’s capabilities across orthopaedics, neurosurgery, and interventional cardiology are expected to further strengthen Futura Medtech’s positioning as a comprehensive medical devices company serving diverse clinical segments.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.